June 11, 2025

Simvastatin Lowers Cholesterol—but Does Not Improve Depression Symptoms

A randomized trial of 160 adults with depression and obesity found no improvement in mood symptoms from adding simvastatin to escitalopram, though the statin significantly lowered cholesterol and inflammation levels.

Conexiant

June 11, 2025

Does Paracetamol Block Peripheral Pain?

A newly published study showed that a metabolite of paracetamol can directly block sodium channels in peripheral pain-sensing neurons, helping reduce pain without acting on the brain.

Conexiant

June 10, 2025

Cancer Pain Study Shows Promise for Novel Neurotoxin

A Phase I study of intrathecal resiniferatoxin in patients with advanced cancer pain shows promising reductions in pain and opioid use, with durable effects and manageable side effects.

Conexiant

June 10, 2025

Heavy Drinking Ups Pancreatic Cancer Risk, Large Study Finds

Each 10-g increase in daily alcohol intake was linked to a 3% rise in risk.

Conexiant

June 10, 2025

FDA Pledges Week-Long Drug Reviews

New leadership outlines accelerated approval processes, AI integration, and food additive restrictions to address the chronic disease epidemic

Conexiant

June 09, 2025

Sleep Signals May Shape Survival Odds

A new study found that a shorter time gap between melatonin production and sleep midpoints may be linked to longer survival among women with advanced breast cancer.

Conexiant

June 09, 2025

Urinary Retention Rising After Knee Replacement Surgery

A large U.S. hospital database study found that postoperative urinary retention after knee replacement is rising and linked to complications, especially in older men and patients with certain health conditions.

Conexiant

June 09, 2025

Postpartum Sleep Stays Fragmented for 13 Weeks

New research found that first-time mothers experienced substantial sleep disruption for more than 3 months after childbirth, even as total sleep time gradually recovered.

Conexiant

June 09, 2025

Does Autism Increase Parkinson Risk?

A cohort study of more than 2 million individuals found that autism spectrum disorder was associated with a more than fourfold increased risk of Parkinson disease before age 50 years, even after adjusting for psychiatric medication use and depression.

Conexiant